In a much-needed bit of good news for the Huntington's disease community, Neurocrine Bioscience's KINECT-HD trial showed that treatment with valbenazine significantly reduced the involuntary movements called chorea
As promised, HDBuzz's Jeff Carroll finally signed up for the Enroll-HD study. Learn more about this important global HD "observational study" here.
For the first time in HD research, an animal model has been created in pigs using 2 cutting edge DNA editing t
Deutetrabenazine becomes the first new drug in a decade licensed by the FDA for symptoms of Huntington's disease
A new scientific paper & lots of headlines about deutetrabenazine, a twist on treating chorea in Huntington's disease
Modified 'heavy hydrogen' form of tetrabenazine appears safe and effective for chorea in Huntington's disease
Two studies show exercise benefits for some symptoms of Huntington's disease. Just don't believe everything you read.
Video from day 2 of Buzzilia: nightly news, interviews and features from the HD World Congress 2013 in Brazil
Proper contraction of muscles is crucial for coordination; errors in this process might help explain movements in HD